Pharmaceutical composition containing a block copolymer bound to a boronic acid compound
A pharmaceutical composition includes a block copolymer having a hydrophilic segment, a hydrophobic segment, and a boronic acid compound bound to a side chain of the hydrophobic segment via a linker moiety that includes a heterocyclic structure. The heterocyclic structure contains a cyclic skeleton that includes a boron atom of the boronic acid compound, one or two atom(s) X bound to the boron atom and selected from an oxygen atom and a nitrogen atom, and one or two carbon atom(s) (respectively) bound to the atom(s) X. The block copolymer further includes at least one organic group bound to the carbon atom(s). The organic group(s) contain(s) an aromatic group or cyclic alkyl group that sterically protects a boronic acid ester bond and/or a boron amide bond resulting from bonding between the boron atom and the atom(s) X.
1. A pharmaceutical composition comprising a block copolymer having the following chemical structure:
wherein:
m is an integer of 40-500;
n is an integer of 20-80;
x is an integer of 0-79 with the proviso that x is less than n;
the n-x groups and the x groups are arranged in a random sequence.
2. The pharmaceutical composition according to claim 1 having the following chemical structure:
wherein:
m is 161;
n is 40;
x is 30.
3. A pharmaceutical composition having the following chemical structure:
wherein:
m is 161;
n is 40;
x is 11; and
the n-x groups and the x groups are arranged in a random sequence.